Neutra Corp (OTCMKTS:NTRR) Comes Up With Yet More News

After hiring a new member of the management team in August 6, Neutra Corp (OTCMKTS:NTRR) informed us that Illinois has become the 21st state to legalize medical marijuana (MMJ) on August 8. They also started developing a revolutionary horticulture technology on August 13 and a couple of days later, they said that the sales of medical weed have surpassed expectations. All this in just nine days, but it would appear that the stream of new information hasn’t stopped.

Yesterday, a couple of hours before the start of the trading session, they issued their next in a long line of press releases, this time telling us that they are now working on a new nutraceutical delivery system that is supposed to bring a smokeless way for MMJ patients to take their medicine. This means that NTRR have issued a total of five press releases in just two weeks and suggests that they’re working flat out to get everything together.

That’s all well and good, but so far, the fruits of their labor remains somewhat chimerical. They entered the medical cannabis business at the end of March and while we know that commercialization is never done in just four months, we have yet to see any update on the development of their magical MMJ products infused with healthy nutraceuticals. In fact, a large portion of their press releases sound too generic and carry way too little information to be of any use to the regular trader who is contemplating his/her potential investment options.

We’re not even sure about the few announcements that speak of something that could really influence the company’s future. Take the joint venture with an entity called Second Wave Ventures, LLC, for example. NTRR‘s PR department has been talking about it for quite a while now and yet, the latest 10-Q doesn’t appear to even mention the candidate partner.

What’s more, as far as Google Search is concerned, Second Wave Ventures doesn’t seem to exist outside NTRR‘s press releases and that brings up yet more questions around the potential success of the partnership that, by the looks of things, isn’t even in effect at the moment.

With so few cold hard facts, we can only guess what NTRR‘s future will be, but in the meantime, there’s something else that’s deeply worrying – the ticker’s behavior. It’s not uncommon for a penny stock to move up or down under the influence of some exciting announcements, but the factor that separates the proverbial men from the proverbial boys is the long term performance.

Unfortunately, NTRR is not high on our list of companies displaying any sort of consistent chart movement. You can see from the graph at the beginning of the article that the announcement of the new medical marijuana business triggered some extraordinary trading and resulted in prices way higher than anyone was expecting. Soon after, however, it all went pear-shaped and, as we mentioned yesterday, the losses for some of the investors who got a bit carried away by the hype amounted to no less than 95% a couple of weeks ago.

The flurry of new press releases meant that some signs of waking up were displayed and yet, the 7% correction from yesterday and the fact that right now, about an hour into the session, the ticker is still sliding might suggest that another drop is in store.

In that respect, NTRR‘s chart might start to look a lot like the one for Medical Marijuana Inc (OTCMKTS:MJNA) whose shareholders have been on something of a roller coaster for quite some time. MJNA, however, have proven their ability to generate revenues. They also seem to be on their way to profitability and, unfortunately, we can say neither of these things about NTRR at the moment.